Philippines approves emergency use of Novavax COVID-19 vaccine

Reuters2021-11-17

MANILA, Nov 17 (Reuters) - The Philippines has approved the emergency use of a COVID-19 vaccine by Novavax Inc , its food and drug agency chief said on Wednesday, the ninth vaccine approved in the Southeast Asian country.

The nanoparticle vaccine, under the brand name Covovax, will be manufactured by Serum Institute of India, and is approved for use on adults 18 and above, the agency's chief Rolando Enrique Domingo told a public briefing.

Covovax, which had efficacy of 89.7% in clinical trials, will be administered in two doses not less than 21 days apart, Domingo added.

The Philippines has inoculated more than a quarter of its 110 million population.

Early this month, Novavax received its first emergency use authorisation from Indonesia. Novavax also filed an application for approval of the vaccine in Canada and with the European Medicines Agency.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • SL1977
    2021-11-30
    SL1977
    shelf life 2 years. This is where nova will beat the rest in long run. 
  • MT8
    2021-11-17
    MT8
    All approved and ship out soon! :)
  • feelyn
    2021-11-17
    feelyn
    至多涨5块钱,也有可能飘红
  • TonyPSH
    2021-11-17
    TonyPSH
    Good. 
  • jolynnnnnnnn
    2021-11-17
    jolynnnnnnnn
    Consider Covaxin?
发表看法
5